Journal article icon

Journal article

The role of technology in clinical trials using stereotactic body radiotherapy.

Abstract:

Stereotactic body radiotherapy is a highly technology-driven treatment modality. The wider availability of in-room imaging and advanced radiotherapy delivery techniques has led to more institutions offering stereotactic ablative therapy (SABR). While some technological challenges remain, the crucial point for the next generation of SABR clinical trials is that today’s technology is used correctly and close to its optimal potential for accuracy. The credentialing procedure of SABR needs to be ...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.1259/bjr.20160930

Authors


More by this author
Department:
Oxford, MSD, Nuffield Department of Population Health, Clinical Trial Service Unit
Role:
Author
Publisher:
British Institute of Radiology Publisher's website
Journal:
British Journal of Radiology Journal website
Volume:
90
Issue:
1071
Pages:
20160930
Publication date:
2017-03-05
Acceptance date:
2017-01-01
DOI:
ISSN:
1748-880X
Pubs id:
pubs:668880
URN:
uri:4f6b11d7-0f1d-4760-8fb3-7d92b15b7d41
UUID:
uuid:4f6b11d7-0f1d-4760-8fb3-7d92b15b7d41
Local pid:
pubs:668880
Language:
English
Keywords:

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP